Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Monday, October 19, 2026

Back to today

From X

@StableBread

Fajasy on X

Elmet $ELMT expects Masan High-Tech Materials, its Vietnamese tungsten supplier, to stay its key refiner even after a U.S.-funded plant in Nevada comes online, and it bought 4.99% of the company for $124.75M on October 1. Masan High-Tech Materials (UPCoM: MSR) mines tungsten at Nui Phao in Vietnam, refines the concentrate into APT (ammonium paratungstate, the traded form of tungsten) and oxides, and calls itself the largest producer of processed tungsten outside China. Elmet, which turns tungsten into parts for U.S. missiles and jets, has bought from MSR for 12+ years, and the deal values MSR at $2.5B. The 55.1M shares came from a Masan Group (HOSE: MSN) subsidiary, so the $124.75M goes to MSR's parent, not into MSR. Along with the stake come (1) an MSR board seat, (2) an 18-month lockup on Elmet's MSR shares, and (3) 8+ years of supply that MSR puts at ~1,250 tonnes of WO₃ (tungsten trioxide, the standard measure of contained tungsten) a year, ~$1.5B of revenue to MSR at today's prices. That's ~$187.5M a year of spend with MSR ($1.5B / 8), equal to 82% of Elmet's $228.5M of TTM revenue. On September 14, Elmet's deck labeled ~$100M of the U.S. Department of War's (DoW) $450M "Strategic Investments in Elmet Refining & Trading," its new tungsten buying and trading division, to build a "diversified feedstock portfolio." The October 1 deck relabels the same ~$100M "Strategic Investment in Masan," and the stake cost $124.75M. At $2.5B, Elmet paid 10.7x the ~$233M of net profit MSR expects for 2026 ($2.5B / $233M). For context, APT was $3,040/MTU (metric ton unit, 10 kg of WO₃) on May 29, up from $330 in January 2025 per Elmet's deck, and Elmet's own 2031 targets assume $1,500/MTU. Elmet's 8-K also says it won't participate in MSR's 2026 interim dividends. On October 1, the day the shares traded, MSR's board proposed a second 2026 interim dividend of VND 5,000/share (Vietnamese dong). VND 5,000 is 8.5% of the VND 58,760/share Elmet paid, or ~$10.6M on its 55.1M shares. In September I wrote that Springer, the Nevada APT plant, gives Elmet the one step it didn't own: Turning tungsten concentrate into the oxide its powder line starts from. Elmet's deck calls MSR a "long-time supplier and processor of blue tungsten oxide (BTO)," so MSR already handles the conversion for Elmet. So the step Elmet didn't own in July stays with MSR, and Elmet paid 10.7x MSR's expected 2026 profit for its 4.99% while its own 2031 plan assumes APT at under half the May price.
@convequity 1 click

Convequity on X

Convequity’s AI Bubble Barometer (ABBX) — Week of 2 October 2026 Our weekly framework tracks valuations, returns, capex, financing risk and infrastructure capacity across hyperscalers, neoclouds and model labs. Friday 2 Oct 2026 close (US ET): - Price drove the move: EV rose about $44B to about $14,114B. Invested capital (IC) was unchanged at $2,338B. - EV/IC: 6.04x, up 0.02x from 6.02x on 25 Sep. - All-in EV/IC: 6.76x. 1. Returns. Our paired, annualized forward ROIC (which is not trailing accounting ROIC) for Q2 2026 is 30.0%, against an AI WACC of 9.8%: 3.07x ROIC/WACC and a spread of +20.3 percentage points. 2. Capex. Latest-quarter cash capex is $228.7B. 3. Debt. Borrowings are $595B. All-in exposure is $3,624B, or 6.10x borrowings, adding purchase obligations, construction commitments and uncommenced leases on top of borrowings and leases. 4. Gigawatts. Current capacity is 45.7 GW, with 153.4 GW planned. $MSFT versus $GOOGL: MSFT’s all-in exposure is about 17x borrowings, and it is renting more: external capacity is about 12% now and 21% of planned capacity. GOOGL’s all-in exposure is 10.2x borrowings, while its external capacity share remains small at about 4% now. We see a price-led rise in valuation, with modeled forward returns still well above the cost of capital. Future spending commitments are much larger than borrowings alone suggest, and the reliance on rented capacity differs across companies.
@StableBread 1 click

Fajasy on X

My investing thesis in a nutshell (w/examples): 1) Buy with a strong margin of safety or stock price near/below cash and/or book value. 2) Buy in industries and/or markets where the money is flowing. Makes it a lot easier. 3) Buy the best early and/or the most overlooked in that particular industry. 4) Pay up for unfair advantages, excellent mgmt teams, and companies with huge latent pricing power. 5) Sell when the thesis breaks. Or a much better risk/reward setup hits your desk. Otherwise continue to add/hold. Don't track stock prices. Track the main business KPIs like any competent mgmt team would. Example #1: Bought $NBIS 4x mid $20's (best overall). Then bought $BRUN common and warrants pre-merger (most overlooked). Example #2: Bought $FTEK $1.39. Cash floor new excellent operator CEO. Strong upside potential w/data centers. Example #3: Bought $BABA $70's. Strong margin of safety, market leader, unfair advantages. Sold $170 for better risk/reward. Example #4: Bought $ELMT @$19 and @$14. Unfair advantage. Strategic. Cheap. Critical in strong growth industries. Example #5: Bought $TOST @$24. Beaten down due to macro headwinds and new/early $DASH competition. But almost everything in business stronger and expanding to new verticals. Lastly, if you're unsure or don't fully understand the business. Just say no. In fact, say no to most stocks. Most probably your best idea is already in your portfolio. Don't lockup your money in a 3/5 setup, you're trying to make outsized returns! And sub to my newsletter (link in bio) if you want my deep dives. 😉

Investor Letters

All letters

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $525M
Trade Ideas Flow 21 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M
TSOH Investment Research 18 clicks
SKIN · long

Skinhealth Systems INC

SkinHealth Systems owns a dominant professional skincare consumables franchise but trades at roughly $115 million market cap and $255…

SKIN $73M
Value Investors Club 2 clicks

Do You Trust Apple?

Apple’s HomeView strategy ties Siri, privacy and smart-home control to consumer trust in its vision for the home.

AAPL $5T
Stratechery by Ben Thompson – On the business, strategy, and impact of technology. 3 clicks

Semtech Analyst Day Review

Semtech raised Q3 guidance and targets $3.2 billion of fiscal 2030 revenue, excluding upside from its AI data-center optical and copper…

SMTC $13B
CV's Substack 13 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 245

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.